GWM
HIMS icon

Geneos Wealth Management’s Hims & Hers Health HIMS Stock Holding History

Geneos Wealth Management’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96.9K Buy
2,796
+396
+17% +$10.6K ﹤0.01% 1220
2026
Q1 		$49.8K Buy
2,400
+200
+9% +$4.72K ﹤0.01% 1430
2025
Q4 		$71.4K Sell
2,200
-20
-0.9% -$857 ﹤0.01% 1268
2025
Q3 		$126K Buy
2,220
+1,190
+116% +$61K ﹤0.01% 1048
2025
Q2 		$51.3K Buy
1,030
+12
+1% +$542 ﹤0.01% 1555
2025
Q1 		$30.1K Buy
+1,018
New +$37.8K ﹤0.01% 1736
2022
Q2 		– Sell
-2,150
Closed -$11K – 2667
2022
Q1 		$11K Buy
+2,150
New +$10.6K ﹤0.01% 2046

Other funds holding HIMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geneos Wealth Management's HIMS Position: Q2 2026 in Review

Geneos Wealth Management increased its Hims & Hers Health (HIMS) stake by 17% in Q2 2026, buying an estimated $10.6K and bringing the position to 2,796 shares worth $96.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1220.

Geneos Wealth Management first reported a position in HIMS in Q1 2022 and has held it in 7 quarters since. The position peaked at $126K in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Geneos Wealth Management held 2,796 shares of Hims & Hers Health worth $96.9K as of Q2 2026.
  • Geneos Wealth Management bought 396 Hims & Hers Health shares in Q2 2026, an estimated $10.6K.
  • Hims & Hers Health made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1220 holding.
  • Geneos Wealth Management first reported a position in Hims & Hers Health in Q1 2022 and has held it in 7 quarters since.
  • Geneos Wealth Management's Hims & Hers Health position peaked at $126K in Q3 2025.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.